Epiq Capital Group, LLC Nex Immune, Inc. Transaction History

Epiq Capital Group, LLC

  • $269 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
BUY
$0.6 - $17.5 $234,360 - $6.84 Million
390,600 New
390,600 $217,000
Q2 2022

Aug 15, 2022
SELL
$1.61 - $4.68 $306,866 - $892,008
-190,600 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$1.79 - $4.65 $341,174 - $886,290
190,600 New
190,600 $802,000

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $6.04M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Epiq Capital Group, LLC Portfolio

Follow Epiq Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epiq Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epiq Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email